i doubt it, support was found in high 60’s and we’ve reversed. To compelling of an investment to go lower than this support. IMO,
we’re coming into a pivotal time. FDA meeting is really, a matter of weeks away. This is going to lay the foundation of how quickly we can commercialize this in the USA, hopefully late this year or early next year.
anecdotally on this forum and clinically, this is far superior to any alternative on the market. I’m glad we are cashed up to be ready to market the drug when the time comes. Both, MSB and BOT cap raised when FDA approved their drug for marketing ramp up. I’m hoping with our cash on hand in the case of any cap raise could be minimal dilution.
LTP Price at posting:
75.5¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)